GlaxoSmithKline's HIV business ViiV is within weeks of resubmitting its request for approval of its long-acting injection Cabenuva to U.S. drug regulators, ViiV's head of research said on Thursday. ViiV executive Kimberly Smith told a media briefing that the company would stick to its previous guidance of refiling the request around mid-year and that this would happen "within weeks"....
Quincy Krosby, Chief market strategist at Prudential Financial, joins The First Trade to discuss her thoughts on the markets and where investors should be looking. ...
The coronavirus marches on, but healthcare names all over the world are fighting back. Earlier this week, Gilead Sciences (GILD), the manufacturer of COVID-19 antiviral drug remdesivir, revealed the pricing plan for the treatment. A five-day course of remdesivir will be sold to governments of developed nations, including the US, for a price of $2,340 ($390 per vial). US private health insurers will need to fork up $3,120 for the course ($520 per vial). Other countries, though, will find it difficult to get hold of the treatment over the next three months. The Trump administration has purchased over 500,000 doses, which amounts to July’s total production, and 90% of Gilead’s expected output in August and September. Overall, in 2020, Gilead expects to produce up to 3 million courses. Next year, Gilead has set its sights on manufacturing between 600,000 and 800,000 courses a month. The news was greeted with enthusiasm by...
If you are looking for the best ideas for your portfolio you may want to consider some of Amana Mutual Funds top stock picks. Amana Mutual Funds, an investment management firm, is bearish on Alphabet Inc. (NASDAQ:GOOG) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed […]...
China's disciplined approach in isolating and treating those infected with the novel coronavirus allowed the country to re-open sooner. The rest of the world is following China's lead. As the world economy restarts, international stocks will fare the best. Its geographic diversity will work in its favor as strong growth in re-opened countries offsets a temporary shutdown in other places.Savvy investors may build a geographically diversified portfolio, but that is not easy. There are currency exchange rate risks to consider. So, buying worldwide conglomerates may pay off in the long-run. Plus, investors get the benefit of spreading out risks.There are seven international stocks to buy as the world economy restarts:InvestorPlace - Stock Market News, Stock Advice & Trading Tips* The Unilever Group (NYSE:UL)* The Procter & Gamble Company (NYSE:PG)* Alibaba (NYSE:BABA)* Coca-Cola Company (NYSE:KO)* Toyota Motor (NYSE:TM)* Kimberly-Clark (NYSE:KMB)* AstraZeneca (NYSE:AZN) * 7 Utilities Stocks to Buy With Reassuring Dividends Together,...
